Utility of peak anti-Xa monitoring in high-risk bleeding patients on low molecular weight heparin – Can it guide us to safe dosing of Low-Molecular Weight Heparin (LMWH) Leave a Comment / By Ashish Anil Sule, MD / February 25, 2026